Local Vape Retailer Faces Legal Action for Non-compliant Products and Counterfeit Cigarettes

Aug.02.2023
Local vape retailer, J&M Patterson Ltd, faces legal action for selling non-compliant nicotine vape products and counterfeit cigarettes.

Title: Local Vape Retailer Faces Legal Action for Non-compliant Products and Counterfeit Cigarettes

 

In a recent development, Muhammed Shuaab, director of J&M Patterson Ltd, a local nicotine vape retailer located at 33-35 High Street, Alness, has been subjected to legal requirements and restrictions by Tain Sheriff Court. The court order was issued by the High Council Trading Standards following intelligence that Shuaab was selling nicotine vapor (NVP or vape) products that did not comply with product safety and labeling requirements.

 

After a visit and warning from Trading Standards Officers, it was discovered that Shuaab had over 1000 NVPs in his possession that violated the product safety regulations. Consequently, these non-compliant products will now be confiscated and destroyed.

 

The Tobacco and Related Products Regulations 2016 state that the sale or possession of NVPs that do not comply with these rules is considered an offense. Offenders can be sentenced up to 12 months in prison or face a fine of up to £5,000, or both.

 

Particular concern arises from the potential health risks associated with unsafe NVPs lacking proper instructions, warnings, and information, especially for vulnerable individuals. The High Council's Trading Standards also suspects that retailers may be distributing single-use vapes with high nicotine concentrations.

 

Aside from product compliance, the court order imposes specific requirements on the retailer. Mr. Shuaab, as a registered business, is obligated to enforce a strict age verification policy to prevent the sale of NVPs to individuals under 18. Failure to comply with this policy is considered a criminal offense. Furthermore, Mr. Shuaab has been legally mandated to seek written authorization from persons under 18 before selling nicotine vapor products to them.

 

In addition to the non-compliant NVPs, a sleeve of "Richmond Blue" cigarettes, amounting to 200 cigarettes, was found in Shuaab's possession. These cigarettes, suspected to be counterfeit, were seized and handed over to the trademark holder for examination. Counterfeit cigarettes often contain harmful ingredients and lack legal liability for their safety.

 

The unauthorized sale of non-compliant NVPs and possession of counterfeit cigarettes are offenses under the Consumer Protection from Unfair Trading Regulations 2008. Shuaab's actions indicate a breach of the law, as he either falsely declared or intentionally created a misleading impression about his products.

 

Lastly, Shuaab is required to inform the Highland Council of any changes to his business name, personal name, or address for the next five years.

 

This order serves as a warning to all retailers to ensure compliance with product safety regulations and to refrain from engaging in the sale of counterfeit goods. The High Council Trading Standards will continue to monitor and take legal action against those who endanger public health and violate consumer protection laws.

 

Summary: Tain Sheriff Court has issued a court order against Muhammed Shuaab, a local nicotine vape retailer, for selling non-compliant NVPs and possessing counterfeit cigarettes. The order mandates compliance with product safety regulations, age verification policies, and the notification of changes to business details. Failure to adhere to these requirements can lead to imprisonment or fines. The High Council Trading Standards highlights the health risks associated with unsafe NVPs and the potential harm caused by counterfeit cigarettes.

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

FDA PMTA Roundtable: Ongoing Comprehensive Coverage by 2Firsts
FDA PMTA Roundtable: Ongoing Comprehensive Coverage by 2Firsts
Feb.11
PMI Faces Setback in India: Global Regulatory Fragmentation Complicates Its Smoke-Free Transition
PMI Faces Setback in India: Global Regulatory Fragmentation Complicates Its Smoke-Free Transition
India has reaffirmed its 2019 ban on e-cigarettes and heated tobacco devices, effectively blocking Philip Morris International (PMI) from launching IQOS in the country despite years of lobbying. Together with Taiwan, China’s conditional opening of heated tobacco products, and Japan’s planned 2026 excise tax hikes, these moves highlight increasingly divergent national regulatory pathways—an external uncertainty shaping PMI’s smoke-free growth trajectory.
Feb.12
UK Tobacco and Vapes Bill Enters House of Lords Report Stage
UK Tobacco and Vapes Bill Enters House of Lords Report Stage
The Tobacco and Vapes Bill has entered the report stage in the UK House of Lords, with further examination scheduled to begin on February 24, 2026. The legislation aims to create the first “smoke-free generation” by ensuring that individuals who are 15 years old or younger in 2026 can never legally be sold tobacco.
Regulations
Feb.22
Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
A cross-sectional analysis based on the US NHANES 2021–2023 cycle, including 6,262 participants aged over 12, found that compared with people who neither smoke nor vape, those who smoke and/or use e-cigarettes had a higher prevalence of elevated blood pressure and hypertension. After full adjustment, smoking/vaping was associated with elevated blood pressure (aOR 1.34) and hypertension (aOR 1.46), and with a 1.05 mmHg higher diastolic blood pressure.
Feb.09 by 2FIRSTS.ai
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
At the opening of FDA’s PMTA roundtable, small ENDS manufacturers warned that unclear product characterization standards are limiting their ability to invest and raise capital. FDA officials acknowledged industry concerns but said regulatory flexibility is constrained by statutory and procedural boundaries.
Feb.11
JT Delivers Record FY2025 Results as RRP Accelerates and Ploom Expands Globally
JT Delivers Record FY2025 Results as RRP Accelerates and Ploom Expands Globally
JT reported record FY2025 revenue and adjusted operating profit, supported by combustible resilience and accelerating reduced-risk product growth. Heated tobacco volumes surged, led by Ploom. The group confirmed a major three-year RRP investment plan and projected further growth in 2026.
Feb.12